Andrew Krasner: Yes. Thanks for that. We remain confident in our ability to get to the mid-single-digit growth in 2023 and beyond. That’s demonstrated by the organic revenue growth that we achieved this year, reflecting all of the momentum in our businesses. The continued growth from clients seeking our solutions coupled with our robust pipeline and investments that we’re making in our talent strengthens our conviction in our ability to achieve that mid-single-digit organic revenue growth in the future. Our focus remains on enterprise level, long-time organic €“ long-term organic revenue growth target in the mid-single digits and specifically regarding thoughts around the growth profiles of each of our businesses. Probably best to refer you back to our Investor Day materials from September of 21, where we did set some of that out business by business of what we expect long-term for each one of those components.
Gregory Peters: Got it. Thanks for the answers.
Andrew Krasner: Thanks, Greg.
Operator: Our next question comes from the line of David Motemaden with Evercore. Your line is open.
David Motemaden: Hi, thanks. Good morning. I was just wondering if you could size the benefit that the favorable ICT timing had an organic revenue growth in R&B in the quarter? And maybe just talk about how much of a headwind that would be in the first quarter of 2023?
Andrew Krasner: Yes, it’s Andrew. I assume you’re referring to the comment about the timing of the ICT software sales? Is that right, David?
David Motemaden: Yes. That’s right.
Andrew Krasner: So that was stuff that actually we had expected earlier in the year that ended up occurring in the fourth quarter just to when sales cycles close, et cetera. So I think it’s best to look at that business on a full year basis, and that’s in line with our expectations of how that business has performed over the longer term.
David Motemaden: Okay. Got it. That’s helpful. And then just looking at the R&B organic growth, I think it was 6% excluding the book of business drag and I’m calculating around a 2-point also a 2-point benefit from fiduciary income. So I’m getting to around 4% organic if I take out book of business impacts and fiduciary impacts, which is about the same as it was last quarter. So I guess I’m wondering why we didn’t see that €“ or I guess, first, is that right? And if so, why we really didn’t see that growth accelerate versus the third quarter?
Andrew Krasner: Yes. So I think the first point of clarification there is around the Risk and Broking growth rates. So 5% organic €“ 6% organic, excluding the gain on sale and 6% excluding gain on sale and investment income. So it would have been 6% with or without the tailwind from investment income within that line of business.
David Motemaden: Okay. Great. Thanks. I missed that. Thanks for that.
Andrew Krasner: No problem.
David Motemaden: And I guess maybe just one more I’ll sneak one in. Could you just size the adverse impact that the divested reinsurance business in Russia had on free cash flow this year? Because it does feel like a pretty big ramp to get to the low end of the free cash flow target over the next couple of years. So maybe just help us get a sense for what a more normalized free cash flow number would look like if we didn’t have those items would be helpful?
Andrew Krasner: Yes. We did talk a bit about this on the call, the last quarter. So I think we disclosed that the Russia business had about 1% of our total revenue base and a margin of more than double the enterprise margin. So there is some pretty healthy EBITDA cash flow associated with that. Additionally, we did write off a large amount of receivables that were associated with that business, which we were unable to collect. So there’s a fairly sizable headwind, which presented itself from the divestiture and write-off of that business.
